New York - (NewMediaWire) - March 1, 2019 - Weyland Tech Inc. (WEYL) (“Weyland” or the “Company”) will host a conference call to discuss the general overview of the business and recent updates on strategic and corporate initiatives as well as an update on its eWallet business.Weyland will host the call at 12:00 pm. Eastern Time (11:00 pm. Central Time) on Thursday, March 7, 2019. To participate investors may dial-in on 1 (701) 801-1211 and enter the access code: 873-908-258.The conference call will also be made available for replay at 1 (701) 801-1218 with the access code: 873-908-258.The Company will be answering questions provided in advance by shareholders and requests that those be sent by email to: cc@weyland-tech.com.Additionally, callers are asked to join the call promptly at 12:00 PM Eastern Time.About Weyland Tech Inc.Weyland Tech is a global provider of mobile business applications. The Company operates a Platform-as-a-Service (“PaaS”) software used on mobile ‘smartphones’. The PaaS platform offers a mobile presence to Small-to-Medium-Sized- Businesses (“SMB’s”) in emerging markets, with partnerships on 3 continents and growing. The PaaS platform, offered in 14 languages with over 70 integrated modules, enables SMB’s to create native mobile applications (“apps”) for Apple’s iOS and Google Android without technical knowledge or background, empowering SMB’s to increase sales, reach more customers and promote their products and services in an easy, affordable and efficient manner.In May 2018, the Company expanded its portfolio to fintech applications with the launch of its AtoZPay mobile payments platform. The mobile wallet launched in the world’s 4th most populous country, Indonesia, and is already experiencing rapid growth in transactions taking place on the platform.Safe Harbor StatementThis release contains certain “forward-looking statements” relating to the business of the Company. All statements, other than statements of historical fact included herein are “forward-looking statements” including statements regarding: the continued growth of the e-commerce segment and the ability of the Company to continue its expansion into that segment; the ability of the Company to attract customers and partners and generate revenues; the ability of the Company to successfully execute its business plan; the business strategy, plans, and objectives of the Company; and any other statements of non-historical information. These forward-looking statements are often identified by the use of forward-looking terminology such as “believes,” “expects” or similar expressions and involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this news release. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume any duty to update these forward-looking statements.For further information contact: Howard Gostfrand American Capital Ventures, Inc. President Office: 305-918-7000 Email: hg@amcapventures.com www.amcapventures.com

Brookfield, WI - (NewMediaWire) - March 01, 2019 - Trident Brands Inc. (OTCQB: TDNT), a biotech and nutraceutical company, announces a U.S. distribution agreement for their Brain Armor® brand with Threshold® Enterprises, Ltd. This agreement allows Threshold to distribute Brain Armor® products throughout all 50 states in the U.S. Recognized as one of the largest manufacturers and distributors of nutritional supplements and other natural products, Threshold offers more than 450 brands, 18,000 products and distributes to 10,000+ retailers throughout the U.S. and Puerto Rico. This distribution agreement will greatly benefit Brain Armor® Inc., a Trident Brands subsidiary, in its ongoing efforts to achieve country wide distribution and continue its effort to be the market leader in the cognitive health supplement industry.“We are very pleased to have established a national distribution agreement with Threshold Enterprises, Ltd. Their experience and successful track record in distributing high quality supplements in the United States is well known and will be instrumental in growing the Brain Armor® brand as we continue to expand internationally. The entire Brain Armor team is very excited to work with Threshold to make Brain Armor® the brain supplement of choice,” says Mark Cluett, COO of Trident Brands Inc.“Threshold looks forward to representing Brain Armor® across our wide distribution network. We are very impressed with this state of the art brain health supplement line and their scientific and clinical approach. With the help of the entire team at Threshold, we believe that Brain Armor® will be a major player in the brain health supplement market,” says Threshold VP of Sales, Roy McDonald.About Brain Armor® Brain Armor is on a mission to improve cognitive health, well-being and performance at every stage of life and on every field of play. Our products are clinically-proven dietary supplements formulated with omega-3, healthy fats and vital nutrients, designed to support structural brain health and performance. Brain Armor products are vegetarian, made in the USA and are a regular part of many professional and elite amateur athlete and team conditioning programs. Brain Armor Inc. is a subsidiary of Trident Brands Incorporated (OTCQB: TDNT -- tridentbrands.com).For more information on Brain Armor®, please visit www.brain-armor.comAbout Threshold Enterprises, Ltd.Founded in 1978, Threshold Enterprises, Ltd, shares a vision to empower wellness on a global scale by providing fine-quality dietary supplements and nutritional education. Recognized as one of the largest manufacturers and distributors of nutritional supplements and other natural products, Threshold offers more than 450 brands and 18,000 products distributed throughout all 50 states, as well as in international markets. Threshold is dedicated to holistic healthcare, an approach based on treating the entire body, in an effort to achieve optimum wellness. With more than 40 years of experience, Threshold is an honored recipient of awards for the quality of its products, outstanding customer service, educational-based marketing, great deals and discounts, and a successful history of industry advocacy. For more information, please visit www.thresholdenterprises.comAbout Trident Brands, Inc.Trident Brands Incorporated is a publicly-traded nutraceutical company (OTCQB: TDNT), structured to rapidly develop private label, control label, brand label and proprietary ingredient platforms in the dynamic active nutrition, dietary supplement and functional ingredient categories. For more information, please visit www.tridentbrands.com.Forward-Looking StatementsThis press release contains "forward-looking statements" within the meaning of the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995 that are not historical facts. These statements can be identified by the use of forward-looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable ...

MIRAMAR, FL - (NewMediaWire) - March 01, 2019 - Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced the information for its investor conference call, is now available to listen and read on our website www.generex.com.The call updated investors on the previously announced and pending acquisitions that offer significant value to the Generex parent company. Joseph Moscato, Generex President & Chief Executive Officer, discussed the company’s financing plans relating to the acquisitions, as well as the strategic focus of Generex for 2019 and beyond. Topics that were covered include:Potential Acquisition of 13 Hospitals as well as Hospital IT and Management companyPotential Acquisition of World Class Nutraceutical CompanyPotential Acquisition of Home Delivered Medically Approved Foods Business for Chronic Care of diabetes, cancer, cardiovascular, and rheumatoid arthritis patientsAcquisition of Direct to Patient End to End Pharmacy BusinessUpdate on Fuse Medical AcquisitionUpdate on Medisource Partners AcquisitionUpdate on Pantheon AcquisitionUpdate on NuGenerex Immuno-Oncology (NGIO) dividend and Go Public StrategyAcquisition plans for NGIO Merger with Company with Synergistic PlatformsNGIO Acquisition of World Class IPDiscussion of financial and legal issueAbout Generex Biotechnology Corp.Generex Biotechnology is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. Generex is building a new kind of healthcare company that extends beyond traditional models providing support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care.In addition to advancing a legacy portfolio of immune-oncology assets, medical devices, and diagnostics, the Company is focused on an acquisition strategy of strategic businesses that complement existing assets and provide immediate sources of revenue and working capital. Recent acquisitions include a management services organization, a network of pharmacies, clinical laboratory, and medical device companies with new and approved products.Our newly formed, wholly-owned subsidiary, NuGenerex Distribution Solutions (NDS), integrates our MSO network with a pharmacy network, clinical diagnostic lab, durable medical equipment company (DME-IQ), and dedicated call center.Cautionary Note Regarding Forward-Looking StatementsThis release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by introductory words such as "expects," "plan," "believes," "will," "achieve," "anticipate," "would," "should," "subject to" or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Known risks and uncertainties include those identified from time to time in the reports filed by Generex with the Securities and Exchange Commission, which should be considered together with any forward-looking statement. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements. Generex undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Generex claims the protection of the safe harbor for forward-looking statements that is ...

Seattle, WA - (NewMediaWire) - March 01, 2019 - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) and its innovative wellness product line.Most cannabis investors are focused on the medical and recreational cannabis markets, but many ancillary markets are experiencing equally impressive growth. While cannabis industry could hit nearly $150 billion over the coming years, the global wellness industry is already worth upwards of $4 trillion and personal care products generate more than $1 trillion in revenue-an enormous market by anyone's measure.The Yield Growth Corp. is uniquely positioned to capitalize on these ancillary markets with more than 70 wellness products in its pipeline, 29 products registered with Health Canada, and 11 provisional patents filed in the United States.Click here to receive an investor presentation and corporate updatesCFN Media caught up with Yield Growth at the O'Cannabis Conference & Expo in Vancouver:Cannot view this video? Visit:https://www.youtube.com/watch?v=-UZGSm1hM74Follow this link to see the interview: https://www.cannabisfn.com/cfnvideo/?id=vAjwFFwcCannabis in SkincareThe global skincare market is projected to reach $135 billion by 2021, according to Lucintel, driven by increasing consumer awareness. Many skincare brands are also launching multi-functional products that combine beauty benefits, such as anti-aging or anti-blemish properties, and functional benefits, such as protection from the sun or anti-inflammation properties. These functional products are expected to experience the most growth over time.Most hemp skincare products use hemp seed extracts that are naturally rich in omega-6 and omega-3 fatty acids. These compounds naturally hydrate the skin by forming a protective seal over the surface, providing benefits similar to olive oil and other natural oils. Unlike cannabis extracts, hemp seeds do not contain any psychoactive tetrahydrocannabinol (THC) and small quantities of cannabidiol (CBD) that could provide anti-inflammatory benefits. Conversely, Yield Growth's Urban Juve brand utilizes hemp root oil in its line of skin and body care products.According to Hemp Business Journal, the hemp industry surpassed $1 billion in revenue last year. Personal care, the second largest segment of the industry after supplements, generated nearly $200 million in revenue last year. These trends underscore the widespread popularity that hemp has enjoyed across the skincare and wider beauty industry-popularity that investors should consider when diversifying their portfolios.Click here to receive an investor presentation and corporate updatesUrban Juve's ApproachYield Growth's Urban Juve subsidiary has already launched more than ten hemp-based skincare products, including six newly launched face mists and ritual oils. By this summer, the company hopes to have launched more than 30 different products targeting the broader $4.2 trillion wellness industry. The team has a total pipeline of more than 60 wellness formulas, 29 products registered with Health Canada, and 11 provisional patents in the United States.The company's overarching focus is on hemp root oil rather than hemp seed oil. While hemp seed oil provides many benefits, hemp root oil includes alkaloids, ketones, and terpenes that enhance absorption and provide other anti-inflammatory benefits. These properties are widely published in ancient Chinese and Indian literature, but hemp root oil has only recently become more widely known in the Western world.A 1971 study found that many of the terpenes found in the above ground part of the plant are also found in the root, with some minor terpenes in much higher concentrations. Terpenes are known penetration enhancers or natural absorption promoters and are considered the most highly advanced and proven category of compounds for that purpose. The high bioavailability of Hemp Root Oil is due to the ...

New York, NY - (NewMediaWire) - March 01, 2019 - KYN Capital Group Inc. (OTC: KYNC) announced today that new CEO, Ms. Maria Daniels, is actively working with the note holders and larger shareholders to retire larger debts and shares. She is also diligently working for potential JVs. and acquisitions, which she plans to close before the end of the 1st quarter 2019.Maria Daniels stated, “We look forward to make some major updates within next few weeks that will increase the shareholder value.”About KYN Capital GroupKYN Capital Group, Inc. (OTC: KYNC) is a holding company of diverse companies with a focus in sustainable agriculture, nutraceuticals, and alternative energy. KYN Capital Group, Inc. also offers technical services geared for protection in corporate computing and security applications for cloud. http://kyncapitalgroup.com/. Notice Regarding Forward-Looking StatementsThis news release contains forward-looking statements, which reflect our views with respect to future events and financial performance. These forward-looking statements are subject to certain uncertainties and other factors that could cause actual results to differ materially from such statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. KYN Capital disclaims any obligation to update any forward-looking statement made herein.Contact Information: Susan Williams, PR Coordinator KYN Capital Group, Inc. 535 Fifth Avenue, 4th Floor New York, NY 10017 email: info@kyncapitalgroupinc.com

West Palm Beach, FL - (NewMediaWire) - March 01, 2019 - Ethema Health Corporation (OTCQB: GRST) (“Ethema” “GRST” or the “Company”), a provider of healthcare services, today announced that it has signed a letter of intent to purchase a 33.33% interest in Local Link Wellness, LLC (“Local Link”), a mental health and wellness provider with offices located in Melville, NY and East Mauritius, NY. Local Link provides trauma informed counselling services through licensed therapists and case management services for New York and New Jersey based employee groups, including large uniformed and construction patient populations. Additionally, Local Link provides members assistance services for construction unions, including prevention, wellness, and mental health trainings, as well as referrals to appropriate levels of care concerning substance use disorder and mental Health services when indicated after assessment. Ethema’s subsidiary, Addiction Recovery Institute of America, LLC (ARIA), will work jointly with Local Link to promote health and wellness plans to employee groups.There is a growing demand for specialized and comprehensive programs focused on wellness, mental health, and substance abuse. Work place incidents related to wellness concerns are growing rapidly and the cost of care associated with treatment is exploding. These issues are all generally related and a coordinated approach is necessary for effective treatment and cost reduction. “At Ethema, we know what needs to be done to deliver the services necessary to treat substance use disorders. Local Link will be a key partner in helping us get the message out to employers faced with wellness issues in the workplace and help with the delivery of services,” said Shawn Leon, President and CEO of Ethema Health Corporation. “We look forward to working together and providing solutions to employees facing these difficult issues”. "It has become abundantly clear to us, through the years of working in members assistance, that the way to best help those in need is for longer term support, involving, professionals, family and peers with a sustained and tracked treatment protocol,” said Mary Fogarty, President of Local Link. “As we have come to know the leadership at Ethema, we have come to know that we are ethically aligned and we are pleased to be a part of the continued care, for sustainable outcomes. We look forward to partnering with Mr. Leon and the Ethema team, whose profound understanding of the behavioral healthcare space will enhance our mission of providing therapeutic and holistic treatment to patients in need.”About Ethema Health CorporationEthema Health Corporation (OTCQB: GRST) operates in the behavioral healthcare space specifically in the treatment of substance use disorders. Ethema developed a unique style of treatment over the last six years and has had much success with in-patient treatment for adults. Ethema will continue to develop world class programs and techniques with its expansion in the United States. The Company currently has under twenty employees and operates in West Palm Beach, Florida. For more information you can visit our website at www.ethemahealth.com and www.ariafl.comAbout Local Link Wellness, LLCLocal Link has two offices that provide comprehensive mental health counseling for both adult and adolescents, falling under the scope of practices of state licensed LCSW’s. All services provided by Local Link are trauma informed. The Company offers support for the family as well as for the identified client. For more information on Local Link, visit the Company’s website at www.llwcenters.com.Notice Regarding Forward-Looking StatementsThe information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed ...